← Back to Search

SENSE Theatre for Autism

N/A
Waitlist Available
Led By Blythe A Corbett, Ph.D.
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Peers must be at least 18 years of age
Confederates must be at least 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pretest, week 5, week 11, two-month follow-up
Awards & highlights

Summary

This trial tests SENSE Theatre®, a program that uses acting to help adults with autism improve their social skills. It focuses on practicing face recognition and social interactions through repeated role-playing activities. The goal is to see if these improvements last. SENSE Theatre® is a novel intervention that combines trained peers to facilitate performance-based theatrical treatment in a supportive, community-based environment.

Who is the study for?
This trial is for adults with Autism Spectrum Disorder (ASD) who are not in educational programs. They must have an IQ of 70 or above, be diagnosed by a specialist confirmed with ADOS-2, and show interest in improving social skills. Excluded are those with suicidal tendencies, uncontrolled aggression, intellectual impairment below the set IQ threshold, or previous SENSE Theatre participants.
What is being tested?
SENSE Theatre is being tested as an intervention to improve social competence in adults with ASD. It uses peer models, scripted and improvised role-play from theatre techniques to enhance social cognition and behavior through repeated practice.
What are the potential side effects?
There may not be traditional medical side effects since this is a behavioral intervention; however, participants might experience anxiety or stress during performances or interactions. The impact varies among individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 18 years old.
Select...
I am at least 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pretest, week 5, week 11, two-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and pretest, week 5, week 11, two-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Contextual Assessment of Social Skills
Change in Incidental Face Memory
Change in Social Responsiveness Scale - Parent (SRS)
+1 more
Secondary study objectives
Adaptive Behavior Assessment System (ABAS) - Parent-Report
Adaptive Behavior Assessment System (ABAS) - Self-Report
Cambridge Face Memory Test
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SENSE TheatreExperimental Treatment1 Intervention
A peer-mediated, theatre-based intervention designed to improve social cognition and behavior.
Group II: Waitlist Control GroupActive Control1 Intervention
This group will not receive the intervention during the testing phase of the intervention but will eventually receive the theatre intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SENSE Theatre
2014
N/A
~460

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Autism Spectrum Disorder (ASD) that use behavioral strategies and role-play, such as those in SENSE Theatre®, work by enhancing social cognition and behavior. These treatments involve trained peer models, predictable and flexible role-play, and repeated performance of social skills. This structured yet dynamic approach helps individuals with ASD practice and internalize social interactions, which is crucial for improving their social communication abilities and reducing social anxiety.
What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.Outcomes and moderators of Early Start Denver Model intervention in young children with autism spectrum disorder delivered in a mixed individual and group setting.Neural Mechanisms of Qigong Sensory Training Massage for Children With Autism Spectrum Disorder: A Feasibility Study.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
888 Previous Clinical Trials
934,861 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,336 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,869 Previous Clinical Trials
2,777,463 Total Patients Enrolled
83 Trials studying Autism Spectrum Disorder
40,524 Patients Enrolled for Autism Spectrum Disorder
Blythe A Corbett, Ph.D.Principal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
136 Patients Enrolled for Autism Spectrum Disorder

Media Library

SENSE Theatre Clinical Trial Eligibility Overview. Trial Name: NCT04349644 — N/A
Autism Spectrum Disorder Research Study Groups: SENSE Theatre, Waitlist Control Group
Autism Spectrum Disorder Clinical Trial 2023: SENSE Theatre Highlights & Side Effects. Trial Name: NCT04349644 — N/A
SENSE Theatre 2023 Treatment Timeline for Medical Study. Trial Name: NCT04349644 — N/A
~15 spots leftby Sep 2025